RGENTA
Live / Applied — Second extension granted (statement of use) (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 21 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98612574
- Mark type
- Stylized text
- Filed
- 21 Jun 2024
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological, neurological, immunological, cardio-metabolic, and rare diseases and disorders
Owner
- Rgenta Therapeutics, Inc., Woburn, MA, US
- Rgenta Therapeutics, Inc., Woburn, MA, US
Prosecution history
- 20 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2026 — SOU EXTENSION 2 GRANTED
- 20 Feb 2026 — SOU EXTENSION 2 FILED
- 20 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2025 — SOU EXTENSION 1 GRANTED
- 02 Sept 2025 — SOU EXTENSION 1 FILED
- 02 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Dec 2024 — ASSIGNED TO EXAMINER
- 21 Jun 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED